Aicar

AICAR has been used clinically to treat and protect against cardiac ischemic injury

Aicar (5-Aminoimidazole-4-carboxamide)
Cas No: 2627-69-2
MF:C9H14N4O5
MW: 258.23

Assay:98%
Appearance: white powder

Applications: 
Aicar (AICA-Riboside) strongly inhibits the transcription of PPAR&alpha and the coactivation of PPAR&alpha. In adipocyte studies it has been shown to antagonize lipolysis induced by isoprenaline and has been suggested for use in kinase cascade research. Additionally, research indicates that AICAR blocks the differentiation of 3T3-L1 (sc-2243) adipocytes.
AICAR has been used clinically to treat and protect against cardiac ischemic injury.


Specifications:   COA

                    Tests

                  Specifications

Results

Appearance

White powder

Off-White powder

HNMR

Conforms to structure

conforms

LCMS

Conforms to MW

conforms

Assay

≧98.0%

99.3%

Conclusion

Complies with enterprise standard


PREVIOUS:S23 Contraceptive NEXT:NOOPEPT GVS111

INQUIRY